Correction: Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability

Benzer Materyaller

• Correction: Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability
  Yazar:: Valerie Haller, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-01-01)
• SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation
  Yazar:: Liangying Zhang, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-02-01)
• cKIT Mutations in GISTs and Other Malignancies in Thailand
  Yazar:: Thongbliew Prempree, ve diğerleri
  Baskı/Yayın Bilgisi: (2006-03-01)
• Significance of KIT and PDGFRA mutations in gastric gist imatinib - naive surgically treated patients
  Yazar:: Ebrahimi Keramatollah, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-01-01)
• KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST
  Yazar:: Shishan Zhou, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-02-01)